Healthcare Global Enterprises Q2 Results 2026: PAT ₹9 Cr
Q2 FY27 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹732Cr
- Net profit
- ₹9Cr
- Margin
- 18.2%
Guidance rank: #30 of 33 in Healthcare Services
See the sector's top 10 — free with your mobile number.
What the Q2 FY27 call signalled
1 of 4 strong
The short version
HCG expects mid-teens revenue growth rate to continue, with specific clusters like Gujarat projected to normalize to mid-teens growth by Q4 FY 2027. The company expects to maintain mid-teens revenue growth trajectory with targeted acceleration to around 18% growth levels in the medium term.
From Healthcare Global Enterprises Ltd's Q2 FY27 earnings-call transcript · updated 10 Nov 2026.
How did Healthcare Global Enterprises' revenue grow in the September 2026 quarter?
- HCG expects mid-teens revenue growth rate to continue, with specific clusters like Gujarat projected to normalize to mid-teens growth by Q4 FY 2027.
- The company is targeting a growth trajectory of mid-teen revenue growth and high teens EBITDA growth for FY 2028 and FY 2029, with continued margin improvement.
- Volume growth remains strong, with a 9% increase in patient volumes in H1 FY 2027 and expected further expansion, especially in newer clusters like West and East.
- The South cluster is more mature, focusing on increasing procedure complexity, while West, East, and Maharashtra clusters are driving volume expansion.
2 more points from Healthcare Global Enterprises Ltd's call on revenue
Create a free account to keep reading this call
What happened to Healthcare Global Enterprises' margins in Q2 FY27?
See what Healthcare Global Enterprises Ltd said on profitability & margins — free account, 30 seconds.
What capex is Healthcare Global Enterprises planning?
- In H1 FY 2027, the company incurred capex of INR 1,279 million primarily towards capacity expansion, medical equipment, and infrastructure upgrades across the network.
- Key investments include capacity expansion with 25 operational beds added across multiple locations (Kenya, Kolkata, Nagpur), totaling 146 beds operationalized in H1.
- Advancement of medical technologies such as operationalizing an MR-LINAC adaptive radiation therapy system at North Bengaluru hospital and a cardiac surgical robotic system at Ahmedabad.
2 more points from Healthcare Global Enterprises Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Healthcare Global Enterprises raising money or cutting debt?
See what Healthcare Global Enterprises Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Healthcare Global Enterprises' order book?
See what Healthcare Global Enterprises Ltd said on order book & pipeline — free account, 30 seconds.
Healthcare Global Enterprises Ltd — Quarterly revenue & net profit
Healthcare Global Enterprises Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 |
|---|---|
| Revenue | 732 |
| Operating profit (EBITDA) | 133 |
| Operating margin | 18.2% |
| Profit before tax | 17 |
| Net profit (PAT) | 9 |
| EPS (₹) | 0.32 |
Source: Healthcare Global Enterprises Ltd's results filing to NSE (consolidated), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹732 Cr, net profit ₹9 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Healthcare Services
Continue your research
What Healthcare Global Enterprises's management said in earlier quarters
Others in Healthcare Services this season
- Nidan Laboratories & Healthcare (Q2 FY27)
Operating Margin: Not explicitly stated as a percentage; however, total income from operations is Rs 1,201.76 lakhs, so approximate operating margin = (EBITDA…
- Suven Life Sciences (Q2 FY27)
91.92 lakhs for the quarter ended September 30, 2025, indicating a revenue increase of approximately 30.3%. Key results statement takeaways from Suven Life Scie
- Aster DM Quality (Q2 FY27)
Q2 FY27 revenue: INR 2,829 Cr, up 19% YoY from INR 2,382 Cr in Q2 FY26 (Page 6, 9, 10). Key investor presentation takeaways from Aster DM Quality Care Ltd's Q2
- Fortis Healthcare (Q2 FY27)
Patient volume in diagnostics grew 5.8% YoY in Q2 and 9.9% quarter-on-quarter, with test volume growth at 7.2% YoY. Key concall takeaways from Fortis…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM QualityGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Healthcare Global Enterprises Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Healthcare Global Enterprises Ltd Q2 FY27 results?
HCG expects mid-teens revenue growth rate to continue, with specific clusters like Gujarat projected to normalize to mid-teens growth by Q4 FY 2027. The company expects to maintain mid-teens revenue growth trajectory with targeted acceleration to around 18% growth levels in the medium term.
What is Healthcare Global Enterprises Ltd share price analysis?
Healthcare Global Enterprises Ltd currently shows a below-average growth signal. The stock trades at a P/E of 221.1 with a market cap of ₹8,778 Cr. Investors should review the full earnings analysis for detailed insights.
Is Healthcare Global Enterprises Ltd planning capital expenditure?
In H1 FY 2027, the company incurred capex of INR 1,279 million primarily towards capacity expansion, medical equipment, and infrastructure upgrades across the network.
Keep Healthcare Global Enterprises Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.